Our hope was that the CRLs would be coming out more often, thereby keeping biotech companies honest.

FORBES: Parts Of Secret FDA Letter Released -- Don't Expect It To Happen Often

The basic explanation: Alexza was in the rare situation of having already gotten CRLs, and the FDA had to ask permission before making them public.

FORBES: Parts Of Secret FDA Letter Released -- Don't Expect It To Happen Often

The good news: Those really were CRLs.

FORBES: Parts Of Secret FDA Letter Released -- Don't Expect It To Happen Often